About
Delivery system for immune triggers
Areas of Focus
Categories
Drug Delivery & FormulationAustralia
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
129
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07026279Lead Sponsor
A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer
PHASE1/PHASE2Recruiting
67 participants
Started: Aug 18, 2025 · Completed: Jul 31, 2029
NCT05355298Lead Sponsor
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
62 participants
Started: May 31, 2022 · Completed: May 1, 2026
Locations (1)
Headquarters
Melbourne, Australia
Map
Loading map...